AN ASSESSMENT OF MELDONIUM THERAPY EFFECT ON NR2 PEPTIDE LEVEL IN PATIENTS WITH ISCHEMIC STROKE

Objective:The main objective of the study was to assess whether Meldonium therapy at a dose of 1000 mg per day can affect the level of NR2 peptide, a product of proteolytic cleavage of N-methyl-D-aspartate receptors (NMDA), in patients who have recently had acute ischemic stroke.Design and method:A